TD Cowen initiates coverage on Wayfair with $51 price target, citing leadership in healthcare software.

From Yahoo Finance: 2025-06-25 18:26:00

TD Cowen initiated coverage on Wayfair (NYSE: W) with a Buy rating and a $51 price target, citing its leadership in healthcare software. Analysts view Wayfair as a key player in SaaS tools for healthcare providers, with structural tailwinds like rising medical billing complexity driving growth. The $51 target reflects confidence in Wayfair’s ability to scale in a messy healthcare system.

A clinical medical professional is seen helping a patient using integrated health information technology software. TD Cowen’s bullish case for Wayfair focuses on fundamentals and sticky software in a sector that can’t afford to fall behind. The firm sees steady growth potential and believes Wayfair can navigate the challenges of the healthcare industry.

While acknowledging Wayfair’s investment potential, some believe other AI stocks offer greater promise with limited downside risk. An AI stock report highlights opportunities for investors seeking high returns and benefits from Trump tariffs and onshoring. For more insights, check out reports on the best and worst Dow stocks and unstoppable stocks that could double your money. No disclosures provided.



Read more at Yahoo Finance: TD Cowen Sets $51 Target on Wayfair